Pumosetrag
Based on 1 publication(s) in Google Scholar
Pumosetrag is a bioavtive small molecular compound.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 153062-94-3
- Formule: C15H17N3O2S
- Masse moléculaire:303.38
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Pumosetrag
MoreVoir tous les produits spécifiques à Isoform 5-HT Receptor
More
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | EC50 |
5.4 nM
Compound: DDP733
|
Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response
Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as effect on serotonin-induced response
|
[PMID: 21146988] |
| HEK293 | EC50 |
9.2 nM
Compound: DDP733
|
Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release
Partial agonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as decrease in 10 uM 5-chloroindole-induced increase in intracellular calcium release
|
[PMID: 21146988] |
Chemical Information
-
CAS No. 153062-94-3
-
Masse moléculaire 303.38
-
Formule C15H17N3O2S
-
SMILES
O=C(C1=CNC(C=CS2)=C2C1=O)N[C@@H]3C4CCN(CC4)C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Expert Opin Pharmacother
Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome. [Abstract]2020 Jan;21(1):73-84. PMID: 31724881
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)